Therapeutics and Vaccines Against Pathogenic Escherichia coli

作者: Marina S. Palermo , José Flores-Figueroa , Mercedes Paredes-Paredes

DOI: 10.1007/978-3-319-45092-6_11

关键词:

摘要: Diarrheagenic E. coli continues to be an important pathogen causing significant illness in animals and humans. Despite the fact that considerable investigations have been done following initial discovery of enterotoxigenic Escherichia (ETEC) enterohemorrhagic (EHEC), there are currently no available licensed broadly protective, ETEC nor EHEC vaccines. The significant, yet unsuccessful efforts obtaining a vaccine candidate provided information on strategies consider future formulations. There now new promising candidates based this pioneering work, even though they not generated successful This chapter is focused outstanding findings their impact human public health.

参考文章(130)
Marta Rivas, Isabel Chinen, Elizabeth Miliwebsky, Marcelo Masana, Risk Factors for Shiga Toxin-Producing Escherichia coli-Associated Human Diseases. Microbiology spectrum. ,vol. 2, pp. 381- 402 ,(2014) , 10.1128/MICROBIOLSPEC.EHEC-0002-2013
Daniel A. Vilte, Mariano Larzábal, Sergio Garbaccio, Mariela Gammella, Bettina C. Rabinovitz, Ana M. Elizondo, Rodolfo J.C. Cantet, Fernando Delgado, Virginia Meikle, Angel Cataldi, Elsa C. Mercado, Reduced faecal shedding of Escherichia coli O157:H7 in cattle following systemic vaccination with γ-intimin C280 and EspB proteins Vaccine. ,vol. 29, pp. 3962- 3968 ,(2011) , 10.1016/J.VACCINE.2011.03.079
Xiang Gao, Kun Cai, Tao Li, Qin Wang, Xiaojun Hou, Renmao Tian, Hao Liu, Wei Tu, Le Xiao, Lihua Fang, Sen Luo, Yuenan Liu, Hui Wang, Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice. Vaccine. ,vol. 29, pp. 6656- 6663 ,(2011) , 10.1016/J.VACCINE.2011.06.106
A. Lundgren, S. Leach, J. Tobias, N. Carlin, B. Gustafsson, M. Jertborn, L. Bourgeois, R. Walker, J. Holmgren, A.-M. Svennerholm, Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein. Vaccine. ,vol. 31, pp. 1163- 1170 ,(2013) , 10.1016/J.VACCINE.2012.12.063
Diana E Thomas, Elizabeth J Elliott, Interventions for preventing diarrhea-associated hemolytic uremic syndrome: systematic review. BMC Public Health. ,vol. 13, pp. 799- 799 ,(2013) , 10.1186/1471-2458-13-799
David R. Smith, Rodney A. Moxley, Robert E. Peterson, Terry J. Klopfenstein, Galen E. Erickson, Sharon L. Clowser, A two-dose regimen of a vaccine against Escherichia coli O157:H7 type III secreted proteins reduced environmental transmission of the agent in a large-scale commercial beef feedlot clinical trial. Foodborne Pathogens and Disease. ,vol. 5, pp. 589- 598 ,(2008) , 10.1089/FPD.2008.0080
Pallavi Gupta, Manglesh Kumar Singh, Yamini Singh, Vandana Gautam, Subodh Kumar, Om Kumar, Ram Kumar Dhaked, Recombinant Shiga toxin B subunit elicits protection against Shiga toxin via mixed Th type immune response in mice. Vaccine. ,vol. 29, pp. 8094- 8100 ,(2011) , 10.1016/J.VACCINE.2011.08.040
Thomas C. Dowling, Pierre A. Chavaillaz, David G. Young, Angela Melton-Celsa, Alison O'Brien, Claire Thuning-Roberson, Robert Edelman, Carol O. Tacket, Phase 1 Safety and Pharmacokinetic Study of Chimeric Murine-Human Monoclonal Antibody cαStx2 Administered Intravenously to Healthy Adult Volunteers Antimicrobial Agents and Chemotherapy. ,vol. 49, pp. 1808- 1812 ,(2005) , 10.1128/AAC.49.5.1808-1812.2005